International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 19-23 , July 2010

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals

  • Gisele Peirano

      Affiliations

    • Division of Microbiology, Calgary Laboratory Services, Calgary, AB, Canada
    • Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, AB, Canada
  • ,
  • Mike Costello

      Affiliations

    • Division of Microbiology, ACL Laboratories, Rosemont, IL, USA
  • ,
  • Johann D.D. Pitout

      Affiliations

    • Division of Microbiology, Calgary Laboratory Services, Calgary, AB, Canada
    • Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, AB, Canada
    • Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, AB, Canada
    • Corresponding Author InformationCorresponding author. Present address: Calgary Laboratory Services, #9, 3535 Research Road NW, Calgary, AB, Canada T2L 2K8. Tel.: +1 403 770 3309; fax: +1 403 770 3347.

Received 22 December 2009 ,Accepted 18 February 2010.

References 

  1. Rossolini GM, D’Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect. 2008;14(Suppl. 1):33–41
  2. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52–59
  3. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159–166
  4. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis. 2008;14:195–200
  5. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61:273–281
  6. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12:83–88
  7. Pitout JD, Gregson DB, Campbell L, Laupland KB. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother. 2009;53:2846–2851
  8. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53:2227–2238
  9. Marcadé G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, et al. Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother. 2009;63:67–71
  10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
  11. Pitout JD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, et al. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother. 2007;51:1281–1286
  12. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006;50:2872–2874
  13. Pitout JD, Wei Y, Church DL, Gregson DB. Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6)-Ib-cr. J Antimicrob Chemother. 2008;61:999–1002
  14. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, Graves L, et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol. 2005;43:1045–1050
  15. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239
  16. Pitout JD, Campbell L, Church DL, Wang PW, Guttman DS, Gregson DB. Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. J Clin Microbiol. 2009;47:1212–1215
  17. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother. 2009;64:274–277
  18. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555–4558
  19. Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother. 2005;49:4667–4670
  20. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219–228
  21. Bush K. Extended-spectrum β-lactamases in North America, 1987–2006. Clin Microbiol Infect. 2008;14(Suppl. 1):134–143
  22. Moland ES, Black JA, Hossain A, Hanson ND, Thomson KS, Pottumarthy S. Discovery of CTX-M-like extended-spectrum β-lactamases in Escherichia coli isolates from five US States. Antimicrob Agents Chemother. 2003;47:2382–2383
  23. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of newer β-lactamases in Gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol. 2006;44:3318–3324
  24. Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother. 2007;51:4015–4021
  25. Castanheira M, Mendes RE, Rhomberg PR, Jones RN. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb Drug Resist. 2008;14:211–216
  26. Freeman JT, Sexton DJ, Anderson DJ. Emergence of extended-spectrum β-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States?. Clin Infect Dis. 2009;49:e30–e32
  27. Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother. 2008;52:3814–3816
  28. Doi Y, Adams J, O’Keefe A, Quereshi Z, Ewan L, Paterson DL. Community-acquired extended-spectrum β-lactamase producers, United States. Emerg Infect Dis. 2007;13:1121–1123
  29. McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. Prevalence of CTX-M β-lactamases in Philadelphia, Pennsylvania. J Clin Microbiol. 2009;47:2970–2974
  30. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009;53:4733–4739
  31. Nicolas-Chanoine MH, Jarlier V. Extended-spectrum β-lactamases in long-term-care facilities. Clin Microbiol Infect. 2008;14(Suppl. 1):111–116
  32. Johnson JR, Jorgensen JH, Lewis IIJ, Robicsek A, Menard M, Clabots C, et al. CTX-M-15-producing Escherichia coli in the United States: predominance of sequence type ST131 (O25:H4). In: Proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25–28 October 2008, Washington, DC. Washington, DC: ASM Press; 2008;[Abstract K-3444]
  33. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol. 1990;172:6175–6181
  34. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis. 2001;183:78–88

PII: S0924-8579(10)00100-7

doi: 10.1016/j.ijantimicag.2010.02.016

International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 19-23 , July 2010